Patent · US Expired

Solid dosage form for the ocular administration of an active principle, a soluble, solid ophthalmic insert and the production method thereof

US8663678B2 · kind B2 · utility

0Cited by
5References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2002
Grant dateMar 4, 2014
Priority date
Expiry dateApr 26, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A solid dosage form for the ocular administration of an active principle includes at least one biocompatible, water-soluble excipient for ophthalmic use. The form is obtained using a method which is selected from among the following: direct compression, dry compression, wet compression, compression of a lyophilizate, the compression being carried out a temperature below 45° C., or lyophilization, such that the form can disintegrate and release the active principle in the conjunctival sac. The invention also relates to an ophthalmic insert having the aforementioned dosage form which is appropriately dimensioned for ocular administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.